Cyclosporine Promotes Epstein-Barr Virus-Infected Human B-Cell Transformation Assayed by Three Correlated Assay Methods

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 366-370

  Chen, C ^a   Johnston, T D ^a   Jeon, H ^a   Gedaly, R ^a   McHugh, P ^a   Ranjan, D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ARTICLE; B LYMPHOCYTE; CELL COUNT; COLONY FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; PRIORITY JOURNAL; VIRUS INFECTION;

B-LYMPHOCYTES; CELL DIVISION; CELL TRANSFORMATION, VIRAL; CYCLOSPORINE; DNA; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; THYMIDINE;

EID: 60649119392     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.085     Document Type: Article

References (27)

1. Thorley-Lawson D.A. Basic virological aspects of Epstein-Barr virus infection. Semin Hematol 25 (1988) 247
2. Ranjan D., Siquijor A., Johnston T.D., et al. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am Surg 64 (1998) 47
3. Chen C., Johnston T.D., Reddy K.S., et al. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells. J Surg Res 100 (2001) 166
4. Ranjan D., Chen C., Johnston T.D., et al. Stimulation of Epstein-Barr virus-infected human B cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 24 (2006) 147
5. Chen C., Reddy K.S., Johnston T.D., et al. Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression. J Surg Res 113 (2003) 228
6. Caputo J.L., Thompson A., McClintock P., et al. An effective method for establishing human lymphoblastic cell lines using Epstein-Barr virus. J Tissue Cult Methods 13 (1991) 39
7. Moss D.J., and Pope J.H. Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J Gen Virol 17 (1972) 233
8. Kieff E., and Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Field Virology (2001), Lippincott Williams & Wilkins, Philadelphia 2511
9. Ohshima K., Kimura H., Yoshino T., et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58 (2008) 209
10. Depoil D., Fleire S., Treanor B.L., et al. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat Immunol 9 (2008) 63
11. Taylor A.L., Marcus R., and Bradley J.A. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56 (2005) 155
12. Swerdlow S.H. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20 (1992) 373
13. Rogers R.P., Strominger J.L., and Speck S.H. Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. Adv Cancer Res 58 (1992) 1
14. Rezk S.A., and Weiss L.M. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38 (2007) 1293
15. Penn I., and Brunson M.E. Cancers after cyclosporine therapy. Transplant Proc 20 (1988) 885
16. Starzl T.E., Nalesnik M.A., Porter K.A., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1 (1984) 583
17. Levitsky V., and Masucci M.G. Manipulation of immune responses by Epstein-Barr virus. Virus Res 88 (2002) 71
18. Teplova V., Evtodienko Y., Odinokova I., et al. Suppression of mitochondrial permeability transition pore and induction of lymphoma P388 cell death by cyclosporin A. IUBMB Life 50 (2000) 75
19. Hagar H.H. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 151 (2004) 335
20. Mohamadin A.M., El Beshbishy H.A., and El Mahdy M.A. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res 51 (2005) 51
21. Pagano J.S. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc Assoc Am Physicians 111 (1999) 573
22. Johannessen I., and Crawford D.H. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol 9 (1999) 263
23. Khan G., Coates P.J., Kangro H.O., et al. Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J Clin Pathol 45 (1992) 616
24. Ozaki S., Harada K., Watanabe K., et al. Absence of Epstein-Barr virus (EBV) in intrahepatic cholangiocarcinoma confirmed by lack of EBV-coded nuclear RNA and latent membrane protein-1. Histopathology 36 (2000) 50
25. Yamamoto T., Nakamura Y., Kishimoto K., et al. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1. Virus Res 65 (1999) 43
26. Zeidler R., Meissner P., Eissner G., et al. Rapid proliferation of B cells from adenoids in response to Epstein-Barr virus infection. Cancer Res 56 (1996) 5610
27. Ranjan D., Johnston T.D., Reddy K.S., et al. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin. J Surg Res 87 (1999) 1